arrow
Y

Ya-Huei Kuo

city of hope medical center
H指数:24
被引数:2,103

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics

抑制ADSS2-mediated从头合成AMP使急性髓系白血病对BH3模拟物重新敏感

2026-06-260
PRE
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia

张, L.; 康, H.; Valerio, M.; Hoang, D.H.; Pathak, K.; Garcia-Mansfield, K.; 鲁, X.; 郭, W.; 付, Y.H.; 何, X.; 等. 药理抑制miR-126增强Venetoclax在急性髓系白血病中的活性. Blood 2025, 147, 1083–1097. [Google Scholar] [CrossRef] [PubMed]

Blood
IF23.1
2026-03-052
PRE
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia (vol 35, pg 2285, 2021)

细胞质DROSHA和MiR-155生物发生中非经典机制在FLT3-ITD急性髓系白血病中的作用(卷35,页2285,2021)

LEUKEMIA
IF13.4
2025-05-050
PRE
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
2024-02-276
OAAI
Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
2021-10-2234
OAAI